Skip to main content

Table 2 Operative details stratified by sarcopenia

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

  All patients (n = 77)
n (%)
No sarcopenia (n = 47)
n (%)
Sarcopenia (n = 30)
n (%)
p-value
Elective surgery
 Yes 31 (40) 19 (40) 12 (40) 0.581a
 No 46 (60) 28 (60) 18 (60)
Indication for surgery
 Stage 2 surgery for IPPA 6 (8) 3 (6) 2 (7) 0.850
 Stricture 19 (24) 13 (28) 6 (20)
 Fistula 9 (12) 6 (13) 4 (13)
 Medically refractory disease 33 (43) 18 (38) 15 (50)
 Perforation 10 (13) 7 (15) 3 (10)
Type of surgery
 Open 18 (23) 7 (15) 11 (37) 0.153b
 Laparoscopic 52 (68) 35 (75) 17 (57)
 Laparoscopic-assisted 3 (4) 2 (4) 1 (3)
 Open → laparoscopic 4 (5) 3 (6) 1 (3)
Extent of surgery
 Completion proctectomy, ileal pouch anal anastomosis and end-ileostomy 5 (7) 3 (6) 2 (7) 0.557b
 Panproctocolectomy and end-ileostomy 6 (8) 3 (6) 3 (10)
 Sigmoid colectomy 6 (8) 5 (11) 1 (3)
 Ileocecectomy 14 (18) 9 (19) 5 (17)
 Anastomosis revision 1 (1) 1 (2) 0 (0)
 Right hemicolectomy 11 (14) 8 (17) 3 (10)
 Subtotal colectomy and end-ileostomy 27 (35) 15 (32) 12 (40)
 Left hemicolectomy and defunctioning loop ileostomy 1 (1) 1 (2) 0 (0)
 Completion proctectomy and end-ileostomy 3 (4) 1 (2) 2 (7)
 Ileorectal anastomosis 2 (3) 0 (0) 2 (7)
 Anterior resection and end-colostomy 1 (1) 1 (1) 0 (0)
  1. Elective surgery = planned hospital admission for surgery, non-elective surgery = non-planned surgical intervention. IPPA ileal pouch anal anastomosis
  2. a χ2 test, b Fischer’s exact test